Pfizer rides Paxlovid sales to better-than-expected quarter

Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its coronavirus vaccine and top third-quarter expectations. The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion so far this year. Sales from the vaccine Comirnaty, meanwhile, tumbled 66% to $4.4 billion in…

Read More

Political spat over climate risks in investments gets hotter

ST. PAUL, Minn. (AP) — The political fight is only getting fiercer over whether it’s financially wise or “woke” folly to consider a company’s impact on climate change, workers’ rights and other issues when making investments. Republicans from North Dakota to Texas are ramping up their criticism of “ESG investing,” a fast-growing movement that says…

Read More